US Patent Issued to The Brigham and Women's Hospital on July 22 for "Anti-KLRG1 antibodies" (Massachusetts Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,735, issued on July 22, was assigned to The Brigham and Women's Hospital Inc. (Boston).

"Anti-KLRG1 antibodies" was invented by Stefano V Gulla (Medford, Mass.) and Kenneth Evan Thompson (Arlington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to antibodies, or antigen-binding fragments thereof, that specifically binds to killer cell lectin-like receptor G1 (KLRG1). Such antibodies, or antigen-binding fragments thereof, are useful for various therapeutic or diagnostic purposes including treatment of cancers and to increase the effectiveness of vaccines."

The patent was filed on Sept. 6, 2019, under Application No. 17/2...